Ranbaxy Recalls Generic Lipitor In US For Possible Presence Of Glass Particle
By Sreeja V N | November 23, 2012 10:02 PM EST
Ranbaxy Laboratories Ltd, India’s largest drug manufacturer by sales, has announced a voluntary recall of its cholesterol-lowering generic drug -- Lipitor -- from the U.S. market.
Ranbaxy’s U.S. wing, Ranbaxy Pharmaceuticals Inc, has recalled various batches of the Atorvastatin calcium tablets -- a generic version of the Lipitor drug -- from the market, the company has said in a statement.
“Ranbaxy Pharmaceuticals Inc. is conducting a voluntary recall for Atorvastatin calcium tablets, in connection with its 10mg 20mg and 40mg dosage strengths, packaged in 90’s and 500 count bottles and only with respect to certain select lot numbers. The recall does not affect or relate to the 80mg strength,” according to a statement on the company’s website.
Ranbaxy was the first company to launch the generic version of the Lipitor after Pfizer Inc's patent expired in November, 2011. The drug was responsible for generating $600 million in sales for the company.
Ranbaxy had compliance issues with the U.S. Food and Drug Administration (FDA) in the past. The FDA banned shipments from some of Ranbaxy’s manufacturing units in 2009 following which the company agreed to take corrective steps in its plants, Reuters reported.
However, industry experts have said that the current recall indicates that such corrective measures are not adequate and the recall will affect the company’s revenues.
"The development will impact the company's credibility to an extent," said Bhagwan Singh Chaudhary, a research associate at the brokerage IndiaNivesh
"There have been issues in the past (about compliance) and a recall suggests, corrective measures suggested by the US FDA are not being implemented," he added, according to Reuters.
However, Ranbaxy said that the recall was being done keeping customers’ safety in mind and the FDA had full knowledge of the issue.
“The recall is being conducted at the retail level for such select batches that may contain a foreign substance (small glass particles approximately less than 1mm in size). Ranbaxy is proactively recalling the drug product lots out of an abundance of caution, and in keeping the safety of our customers in mind. This recall is being conducted with the full knowledge of the U.S. FDA,” the company said.
Click here for the complete list of the batches of drug being recalled.
To contact the editor, e-mail:
Most Popular Slideshows
- NFL Recap - Week 4: Green Bay Packers 38, Chicago Bears 17 [PHOTOS]
- Derek Jeter With The New York Yankees Through The Years [IN PICTURES]
- Photos Of George Clooney And Amal Alamuddin, They Get Married Again On Monday [Slideshow]
- Taylor Swift's Famous Ex-Boyfriends: From Harry Styles To Joe Jonas [PHOTOS]
Join the Conversation
- LeBron James Was Affected By Miami Heat’s Decision To Release Mike Miller
- Twitter War Erupts After EU Commissioner Calls Celebrities In Nude Selfie Leaked Photos ‘Dumb’
- 'The Amazing Race' Season 25 Spoilers: Episode 2 ‘When You Gotta Go, You Gotta Go’ Airs On Oct. 3, 2014, The 10 Teams Will Race Around The UK For Leg 2 [WATCH VIDEOS]
- 'The Bachelor Australia' Finale Spoiler: Blake Proposes To Top Favourite Of Season 2
- Portland Trail Blazers Pick Up Fourth-Year Option On Point Guard Damian Lillard
- 3 Signs Nexus 6, 8 Release Date Nears: Leaked Pics, KitKat Factory Image & Android L Details Emerge
- Samsung Galaxy Note 4 Available Through O2 For £380, Other Carriers To Follow Soon
- Apple iPhone 6 vs. OnePlus One: With Invitation-Only Model Rested, OnePlus One Can Be A Real Threat To iPhone 6
- ISIS Supporters are Walking Among the Many in the United States – Report
- New Windows OS Is Not Windows 9, Microsoft To Launch Windows 10 As New OS Build
- ISIS Receives Food, Ammunition Due To Mistake Of Iraqi Pilots
- Airstrikes Against ISIS Has Claimed Innocent Lives In Syria, Dubbed ‘Ineffective’ By Jihadi Fighters, US Military To Ask For More Spending Money